📢We are thrilled to showcase some incredible studies recently uploaded to our portal at tomorrow's ‘Spatial Biology: Translating basic research into clinical insights’ in 🇸🇬. Let's makes MxF tissue image visualization and sharing a breeze!
@LitHsinLoo@JoeYeong@abcam
cellXpress, our next-generation spatial profiling software for tissue images, was used to evaluate PD-L1 IHC assays for gastric cancer immunotherapy. Checkout the poster @ASCO and joint paper #GastricCancer next week. Full images hosted @immunoatlas (https://t.co/hqQJqhs5LF)
#ASCO22 News: Significant discrepancies found among PD-L1 assays used in #GastricCancer in KEYNOTE-811 & CheckMate-649 confirmed in research from @NUSingapore, highlighting that these assays aren't interchangeable in practice. https://t.co/KOSqvrZrpO #ASCODailyNews#gicsm
📢We are excited to collaborate with @abcam to create this beautiful set of breast tumor images with a panel of cytolytic T-cells markers.
https://t.co/6EBCieed9h
DM us to share your images and data with the immune-oncology community now!
@LitHsinLoo@JoeYeong@ASTARsg
Particularly in this case, for Abcam antibodies users, they can view/share the raw images and condition that they optimised, as well as the panel design. It would be a great tool for the community! @abcam@AkoyaBio@lunaphore@10xGenomics @nanostringtech #JEDIcouncil4mIFIHC
We believe @immunoatlas revolutionise the way how we showcase/present pathological images in papers/conferences, esp for multiplex IHC/IF. Our pleasure to work with @abcam to deposit mIHC/IF for public access by using the platform that we built in @ASTARsg & @LitHsinLoo.
A great example of a global effort towards a common goal – @ImmunoAtlas is a portal for sharing and referencing #multiplexIHC images and results for #immunooncology. We’re proud to be a part of this important project!
https://t.co/dPP2eAEG7j
@JoeYeong@astar_research
We deposit all images 2 share 2 the community in @immunoatlas as part of our ongoing efforts 2 advocate quality images data sharing for publication, standardization, reproducibility & path 2 clinical. @sitcancer@ProteinAtlas@abcam@HSaterMD@petebankhead https://t.co/KIjsYRFAB8
For those who don't know, I chair the @sitcancer Big Data & Data Sharing Committee. We have our inaugural session at the annual #SITC21 meeting this Saturday at 3:40pm, concurrent session 209: Single cell approaches to advancing understanding of #immunotherapy resistance. 1/4